TY - JOUR
TI - Current concepts in crosslinking thin corneas
AU - Deshmukh, R.
AU - Hafezi, F.
AU - Kymionis, G.
AU - Kling, S.
AU - Shah, R.
AU - Padmanabhan, P.
AU - Sachdev, M.S.
JO - Indian Journal of Ophthalmology
PY - 2019
VL - 67
TODO - 1
SP - 8-15
PB - Wolters Kluwer--Medknow Publications
SN - 0301-4738
TODO - 10.4103/ijo.IJO_1403_18
TODO - collagen;  cross linking reagent;  photosensitizing agent;  riboflavin, cornea;  corneal pachymetry;  diagnostic imaging;  drug effect;  human;  keratoconus;  photochemotherapy;  procedures;  ultraviolet radiation, Collagen;  Cornea;  Corneal Pachymetry;  Cross-Linking Reagents;  Humans;  Keratoconus;  Photochemotherapy;  Photosensitizing Agents;  Riboflavin;  Ultraviolet Rays
TODO - Corneal cross-linking (CXL), introduced by Wollensak et al. in 2003, is a minimally invasive procedure to halt the progression of keratoconus. Conventional CXL is recommended in eyes with corneal thickness of at least 400 microns after de-epithelialization to prevent endothelial toxicity. However, most of the keratoconic corneas requiring CXL may not fulfill this preoperative inclusion criterion. Moderate-to-advanced cases are often found to have a pachymetry less than this threshold. There are various modifications to the conventional method to circumvent this issue of CXL thin corneas while avoiding the possible complications. This review is an update on the modifications of conventional CXL for thin cornea.s. © 2018 Indian Journal of Ophthalmology Published by Wolters Kluwer - Medknow.
ER -